VA Portland Health Care System, Portland, OR, 97239, USA.
Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, 97239, USA.
Nat Commun. 2020 Oct 26;11(1):5406. doi: 10.1038/s41467-020-18961-0.
Mutations in nucleotide-binding oligomerization domain-containing protein 2 (NOD2) cause Blau syndrome, an inflammatory disorder characterized by uveitis. The antimicrobial functions of Nod2 are well-established, yet the cellular mechanisms by which dysregulated Nod2 causes uveitis remain unknown. Here, we report a non-conventional, T cell-intrinsic function for Nod2 in suppression of Th17 immunity and experimental uveitis. Reconstitution of lymphopenic hosts with Nod2 CD4 T cells or retina-specific autoreactive CD4 T cells lacking Nod2 reveals a T cell-autonomous, Rip2-independent mechanism for Nod2 in uveitis. In naive animals, Nod2 operates downstream of TCR ligation to suppress activation of memory CD4 T cells that associate with an autoreactive-like profile involving IL-17 and Ccr7. Interestingly, CD4 T cells from two Blau syndrome patients show elevated IL-17 and increased CCR7. Our data define Nod2 as a T cell-intrinsic rheostat of Th17 immunity, and open new avenues for T cell-based therapies for Nod2-associated disorders such as Blau syndrome.
核苷酸结合寡聚化结构域蛋白 2(NOD2)的突变可引起 Blau 综合征,这是一种以葡萄膜炎为特征的炎症性疾病。Nod2 的抗菌功能已得到充分证实,但调控异常的 Nod2 导致葡萄膜炎的细胞机制尚不清楚。在这里,我们报告了 Nod2 在抑制 Th17 免疫和实验性葡萄膜炎中的一种非传统的、T 细胞内在的功能。用 Nod2 CD4 T 细胞或缺乏 Nod2 的视网膜特异性自身反应性 CD4 T 细胞重建淋巴减少宿主,揭示了 Nod2 在葡萄膜炎中的一种 T 细胞自主、Rip2 独立的机制。在未成熟的动物中,Nod2 在 TCR 连接的下游起作用,以抑制与涉及 IL-17 和 Ccr7 的自身反应样特征相关的记忆 CD4 T 细胞的激活。有趣的是,两名 Blau 综合征患者的 CD4 T 细胞显示出升高的 IL-17 和增加的 CCR7。我们的数据将 Nod2 定义为 Th17 免疫的 T 细胞内在变阻器,并为基于 T 细胞的治疗 Nod2 相关疾病(如 Blau 综合征)开辟了新途径。